CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma
CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma
About this item
Full title
Author / Creator
Publisher
England: Portland Press Ltd The Biochemical Society
Journal title
Language
English
Formats
Publication information
Publisher
England: Portland Press Ltd The Biochemical Society
Subjects
More information
Scope and Contents
Contents
Cyclin B2 (CCNB2) is an important component of the cyclin pathway and plays a key role in the occurrence and development of cancer. However, the correlation between prognosis of low-grade glioma (LGG), CCNB2, and tumor infiltrating lymphocytes is not clear.
The expression of CCNB2 in LGG was queried in Gene Expression Profiling Interactive Analy...
Alternative Titles
Full title
CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8799923
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8799923
Other Identifiers
ISSN
0144-8463
E-ISSN
1573-4935
DOI
10.1042/BSR20211939
